Harwood Private Equity achieved a full exit from its position in Orthoproducts Limited through a sale of the company to a trade buyer on 23 July 2013, creating a return of 3.3x cash multiple and an IRR of 28%.
Orthoproducts is an industry leader in the global orthopaedic implant and equipment market and has 45% market share of the world’s best quality, ultra-high molecular weight polyethylene for knee and hip-joint replacements. Harwood Private Equity acquired the business in 2008.